Classifying lymphoid malignancies: including AI-based pathology, multimodal data, and liquid biopsy скачать в хорошем качестве

Classifying lymphoid malignancies: including AI-based pathology, multimodal data, and liquid biopsy

Laurence de Leval, MD, PhD, Lausanne University Hospital, Lausanne, Switzerland, comments on the potential incorporation of artificial intelligence (AI)-based pathology, multimodal data integration, and liquid biopsy into future classifications of lymphoid malignancies. She states that while novel data is being generated, it's too early to determine what will be included, but emphasizes that classification should prioritize clinically relevant information that influences therapy. This interview took place at the 22nd International Workshop on Non-Hodgkin Lymphoma (iwNHL 2025), held in Cambridge, MA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.